Insider Selling: Allegion (NYSE:ALLE) SVP Sells $1,009,137.42 in Stock

Allegion PLC (NYSE:ALLE) SVP Timothy Eckersley sold 6,417 shares of Allegion stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $157.26, for a total value of $1,009,137.42. Following the sale, the senior vice president directly owned 29,919 shares of the company’s stock, valued at approximately $4,705,061.94. This trade represents a 17.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Allegion Stock Performance

Shares of NYSE ALLE opened at $157.66 on Friday. The stock’s 50-day moving average is $137.75 and its 200 day moving average is $146.70. The stock has a market cap of $13.41 billion, a price-to-earnings ratio of 20.69, a P/E/G ratio of 3.19 and a beta of 0.85. Allegion PLC has a 1-year low of $125.00 and a 1-year high of $183.11. The company has a current ratio of 1.93, a quick ratio of 1.23 and a debt-to-equity ratio of 0.96.

Allegion (NYSE:ALLE) last issued its earnings results on Thursday, July 23rd. The scientific and technical instruments company reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.18. The business had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.12 billion. Allegion had a return on equity of 35.41% and a net margin of 15.36%.Allegion’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.04 earnings per share. Allegion has set its FY 2026 guidance at 8.850-9.000 EPS. On average, sell-side analysts anticipate that Allegion PLC will post 8.92 EPS for the current fiscal year.

Allegion announced that its Board of Directors has initiated a share buyback plan on Tuesday, April 28th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the scientific and technical instruments company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

Institutional Trading of Allegion

A number of institutional investors have recently modified their holdings of the company. Handelsbanken Fonder AB lifted its holdings in Allegion by 43.0% in the 2nd quarter. Handelsbanken Fonder AB now owns 38,900 shares of the scientific and technical instruments company’s stock worth $5,465,000 after buying an additional 11,700 shares during the period. Franklin Street Advisors Inc. NC increased its stake in shares of Allegion by 16.2% during the second quarter. Franklin Street Advisors Inc. NC now owns 2,384 shares of the scientific and technical instruments company’s stock valued at $335,000 after buying an additional 332 shares during the period. Crumly & Associates Inc. increased its stake in shares of Allegion by 20.8% during the second quarter. Crumly & Associates Inc. now owns 2,580 shares of the scientific and technical instruments company’s stock valued at $362,000 after buying an additional 444 shares during the period. Elevation Wealth Partners LLC raised its holdings in shares of Allegion by 1,666.7% during the second quarter. Elevation Wealth Partners LLC now owns 212 shares of the scientific and technical instruments company’s stock valued at $30,000 after acquiring an additional 200 shares in the last quarter. Finally, Czech National Bank raised its holdings in shares of Allegion by 4.4% during the second quarter. Czech National Bank now owns 24,461 shares of the scientific and technical instruments company’s stock valued at $3,437,000 after acquiring an additional 1,031 shares in the last quarter. 92.21% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently commented on ALLE shares. JPMorgan Chase & Co. lifted their target price on shares of Allegion from $150.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, July 24th. Robert W. Baird set a $170.00 price target on shares of Allegion in a research report on Friday, July 24th. Morgan Stanley reduced their price objective on Allegion from $165.00 to $142.00 and set an “equal weight” rating on the stock in a research note on Wednesday, June 3rd. Barclays decreased their price objective on Allegion from $165.00 to $161.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 29th. Finally, Evercore raised Allegion to a “strong-buy” rating in a research note on Monday, April 13th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, Allegion presently has an average rating of “Hold” and a consensus target price of $164.75.

Allegion Company Profile

Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is head­quartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.

The company’s product portfolio spans mechanical locksets, door closers, exit devices, key systems and cylinders, as well as a growing suite of electronic and smart access control offerings.